• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SV-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Nausea (1970); Dizziness (2194); Syncope/Fainting (4411)
Event Date 02/18/2021
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that spaceoar vue was implanted during a spaceoar vue placement procedure performed on (b)(6) 2021.It was reported that, the patient was given 650mg tylenol and 1mg xanax one hour prior to the procedure.While the patient was in recovery following an uneventful and successful spaceoar vue implant, the patient developed an extensive rash on his torso.He also experienced nausea, dry heaves and itching on his lower back progressing to upper back and down thighs.The skin on the back and legs was bright pink with small area of hives.The patient also felt dizziness and passed out approximately 30 to 60 seconds a couple of times.The patient was transferred to a gurney.Emergency medical technician (emt) arrived at 5:00 and patient was assessed and taken to cottage emergency room.The patient was treated with zofran 8mg (odt) and oxygen was also administered prior to being moved to the emergency room.The patient was reported to have fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR VUE SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key11561117
MDR Text Key241982467
Report Number3005099803-2021-01215
Device Sequence Number1
Product Code OVB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182971
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSV-2101
Device Catalogue NumberSV-2101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/26/2021
Initial Date FDA Received03/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-